Page last updated: 2024-11-08

i-cholesterol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

i-cholesterol: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID12309581
MeSH IDM0118486

Synonyms (14)

Synonym
nsc 134930
3,5-cyclocholestan-6-ol, (3beta,5alpha,6beta)-
unii-l551w04084
3alpha,5-cyclo-5alpha-cholestan-6beta-ol
l551w04084 ,
3alpha,5alpha-cyclocholestan-6beta-ol
i-cholesterol
3,5-cyclo-5.alpha.-cholestan-6.beta.-ol
59613-50-2
(3.alpha.,5r,6.beta.)-3,5-cyclocholestan-6-ol
3,5-cyclocholestan-6-ol, (3.alpha.,5r,6.beta.)-
6.beta.-hydroxy-3.alpha.,5-cyclo-5.alpha.-cholestane
cholesterin i
Q27282723
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-199013 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]